Emera Inc is not a strong buy for a beginner, long-term investor at this time. While the company has positive revenue growth and analysts maintain a generally favorable outlook, the declining net income and EPS, coupled with neutral technical indicators and lack of significant trading signals, suggest a wait-and-see approach.
The MACD histogram is negative (-0.292) but contracting, RSI is neutral at 46.397, and moving averages are converging. The stock is trading below the pivot level (52.178), with support at 50.875 and resistance at 53.48. No clear bullish or bearish trend is evident.

Analysts have raised price targets recently, with two maintaining Buy or Outperform ratings.
The MACD and RSI suggest no clear bullish momentum. Hedge funds and insiders show neutral trading sentiment, and there are no recent congress trading data or significant trading signals.
In Q4 2025, revenue increased by 13.78% YoY to $2.006 billion, but net income dropped significantly by 55.84% to $68 million. EPS also fell by 57.69% to $0.22. Gross margin improved by 9.96% to 52.89%.
Analysts have a mixed but generally positive outlook. BMO Capital and TD Securities raised their price targets to C$74 and C$75, respectively, with Buy or Outperform ratings. JPMorgan lowered its price target slightly to C$68 but maintained a Neutral rating.